Skip to main content
Recall Canary
Omnipaque (iohexol) Injection
← Back to all recalls
DRUG RECALLMODERATE

Omnipaque (iohexol) Injection

GE Healthcare is recalling Omnipaque (iohexol) injection due to the presence of particulate matter.

What to do

Contact your healthcare provider if you have concerns about this medication. Do not use the affected product.

Posted
Updated
Recall No.
D-0448-2026
Agency
Firm
GE Healthcare Ireland Limited
Recall ID
98656
Status
ONGOING

Why it was recalled

Presence of particulate matter

How to identify it

UPC 17333197 17333198 17396945 17396948 17396953 17396956 17423503 17423525

GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.

Where it was sold

Distributed in US.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-05 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification